A Narrative Review Of Hydrogen Therapy For COPD: Aging-Related Insights
As we age, chronic obstructive pulmonary disease (COPD) becomes a more significant health concern, often characterized by ongoing inflammation and damage from unstable molecules called free radicals. These factors contribute to the progression of the disease and the aging of our cells.
Recent research has explored a fascinating potential new approach: therapy using molecular hydrogen. This simple molecule has shown remarkable properties that could offer benefits for individuals with COPD. It acts as a selective antioxidant, meaning it can neutralize harmful free radicals without interfering with beneficial ones. It also possesses anti-inflammatory effects, helping to calm the body’s overactive immune responses, and anti-senescence properties, which means it can help combat the signs of cellular aging.
Studies, including both laboratory experiments and human trials, have indicated that administering hydrogen, either through inhalation or by drinking hydrogen-rich water, can lead to positive changes. It has been observed to significantly reduce levels of inflammatory substances and markers of oxidative damage in the body. Furthermore, it can decrease indicators of cellular senescence, which are essentially signs that cells are getting old and losing their function.
In older patients with COPD, clinical observations have shown improvements in blood gas levels (indicating better oxygen and carbon dioxide exchange), a more balanced acid-base status in the body, and enhanced exercise tolerance. These findings suggest that this therapy could be a valuable addition to existing treatments for COPD, particularly for older adults. While the results are promising, further extensive and long-term studies are needed to confirm its effectiveness and determine the best ways to use it.
Source: link to paper